HM Payson & Co’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,000
Closed -$498K 952
2019
Q3
$498K Hold
22,000
0.02% 259
2019
Q2
$555K Hold
22,000
0.02% 259
2019
Q1
$598K Buy
+22,000
New +$738K 0.02% 198
2018
Q4
Sell
-22,000
Closed -$1.03M 257
2018
Q3
$1.03M Sell
22,000
-2,000
-8% -$91.8K 0.05% 173
2018
Q2
$1.04M Hold
24,000
0.04% 179
2018
Q1
$1.33M Hold
24,000
0.06% 158
2017
Q4
$1.28M Hold
24,000
0.05% 174
2017
Q3
$1.03M Hold
24,000
0.04% 182
2017
Q2
$1.45M Hold
24,000
0.07% 160
2017
Q1
$1.67M Sell
24,000
-700
-3% -$48.6K 0.08% 148
2016
Q4
$1.65M Buy
24,700
+700
+3% +$45.5K 0.08% 145
2016
Q3
$1.59M Hold
24,000
0.08% 152
2016
Q2
$1.74M Hold
24,000
0.09% 139
2016
Q1
$1.55M Sell
24,000
-4,000
-14% -$265K 0.08% 142
2015
Q4
$2.01M Hold
28,000
0.1% 139
2015
Q3
$2.15M Hold
28,000
0.12% 135
2015
Q2
$2.08M Hold
28,000
0.1% 138
2015
Q1
$2.03M Hold
28,000
0.1% 139
2014
Q4
$1.85M Hold
28,000
0.09% 141
2014
Q3
$1.53M Hold
28,000
0.08% 150
2014
Q2
$1.63M Hold
28,000
0.08% 146
2014
Q1
$1.74M Hold
28,000
0.09% 139
2013
Q4
$1.5M Hold
28,000
0.08% 144
2013
Q3
$1.41M Hold
28,000
0.08% 144
2013
Q2
$1.28M Buy
+28,000
New +$1.25M 0.08% 146

Other funds holding MD

HM Payson & Co's MD Position: Q4 2019 in Review

HM Payson & Co sold out of Pediatrix Medical (MD) in Q4 2019, closing a stake of 22,000 shares — an estimated $498K sold.

HM Payson & Co first reported a position in MD in Q2 2013 and held it in 25 quarters. The position peaked at $2.15M in Q3 2015. 258 funds tracked by Wall St. Rank hold MD as of Q4 2019.

  • HM Payson & Co reported no remaining Pediatrix Medical position as of Q4 2019 after selling out during the quarter.
  • HM Payson & Co sold 22,000 Pediatrix Medical shares in Q4 2019, an estimated $498K.
  • HM Payson & Co first reported a position in Pediatrix Medical in Q2 2013 and held it in 25 quarters.
  • HM Payson & Co's Pediatrix Medical position peaked at $2.15M in Q3 2015.
  • 258 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2019.

Based on HM Payson & Co's 13F filing for Q4 2019, filed 18 Feb 2020.